Milestone Scientific, Inc. (MLSS) earnings
MLSS earnings moved a median of +0.01% by the close. Quarterly and annual MLSS reports and results, each read against the price at its own news timestamp. Back to the MLSS overview →
24 measured MLSS earnings events.
Where these MLSS earnings landedvs 23 measured MLSS earnings reactions
| Middle 50% of MLSS earnings reactions | -2.67% to +2.79% |
|---|---|
| Median reaction (to close) | +0.01% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 MLSS earnings events with a measured close landed between -2.67% and +2.79%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Milestone Scientific Reports Financial Results for Second Quarter 2026 | Press release | -5.74% | +3.69% | |
| Form 10-Q MILESTONE SCIENTIFIC For: Jun 30 | SEC filing · Form 10-Q | -5.74% | +3.69% | |
| Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call | Press release | — | +3.33% | |
| Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY | Press release | -0.46% | +2.25% | |
| Milestone Scientific Reports Financial Results for First Quarter 2026 | Press release | -0.61% | -6.29% | |
| Form 10-Q MILESTONE SCIENTIFIC For: Mar 31 | SEC filing · Form 10-Q | -0.61% | -6.29% | |
| Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call | Press release | -6.80% | -3.22% | |
| Form 10-K/A MILESTONE SCIENTIFIC For: Dec 31 | SEC filing · Form 10-K | -3.91% | +1.10% | |
| Form 10-K MILESTONE SCIENTIFIC For: Dec 31 | SEC filing · Form 10-K | -0.28% | +6.34% | |
| Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call | Press release | -0.35% | — | |
| Form 10-Q MILESTONE SCIENTIFIC For: Jun 30 | SEC filing · Form 10-Q | +1.69% | +12.05% | |
| Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call | Press release | — | -2.13% | |
| Form 10-Q MILESTONE SCIENTIFIC For: Mar 31 | SEC filing · Form 10-Q | +1.94% | -0.56% | |
| Form 10-K MILESTONE SCIENTIFIC For: Dec 31 | SEC filing · Form 10-K | -6.10% | -6.70% | |
| Form NT 10-K MILESTONE SCIENTIFIC For: Dec 31 | SEC filing · Form NT | -8.19% | -9.46% | |
| Form 10-Q MILESTONE SCIENTIFIC For: Sep 30 | SEC filing · Form 10-Q | -6.07% | -8.19% | |
| Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call | Press release | +0.00% | +0.01% | |
| Form 10-Q MILESTONE SCIENTIFIC For: Jun 30 | SEC filing · Form 10-Q | +1.00% | -1.99% | |
| Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call | Press release | +0.00% | +4.12% | |
| Form 10-Q MILESTONE SCIENTIFIC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.90% | |
| Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call | Press release | +0.00% | -1.85% | |
| Form 10-K MILESTONE SCIENTIFIC For: Dec 31 | SEC filing · Form 10-K | +1.56% | +1.19% | |
| Form 10-Q MILESTONE SCIENTIFIC For: Sep 30 | SEC filing · Form 10-Q | +1.22% | +0.68% | |
| Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call | Press release | +0.00% | +1.32% |
Keep exploring
More MLSS: analyst actions → · SEC filings → · MLSS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Aptose Biosciences, Inc. - Common Shares (APTO) | 152 | -1.33% | 35% |
| MEI Pharma, Inc. (MEIP) | 152 | +0.07% | 51% |
| ProQR Therapeutics N.V. - Ordinary Shares (PRQR) | 152 | -0.42% | 41% |
| METASTAT INC (MTST) | 151 | 0.00% | 13% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.